Growth Metrics

Globus Medical (GMED) Gross Profit (2016 - 2025)

Globus Medical (GMED) has disclosed Gross Profit for 15 consecutive years, with $565.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 43.53% year-over-year to $565.3 million, compared with a TTM value of $2.0 billion through Dec 2025, up 33.51%, and an annual FY2025 reading of $2.0 billion, up 33.51% over the prior year.
  • Gross Profit was $565.3 million for Q4 2025 at Globus Medical, up from $516.5 million in the prior quarter.
  • Across five years, Gross Profit topped out at $565.3 million in Q4 2025 and bottomed at $171.2 million in Q3 2021.
  • Average Gross Profit over 5 years is $298.2 million, with a median of $231.7 million recorded in 2023.
  • The sharpest move saw Gross Profit surged 90.45% in 2021, then fell 0.54% in 2022.
  • Year by year, Gross Profit stood at $188.2 million in 2021, then grew by 8.33% to $203.9 million in 2022, then surged by 72.16% to $351.0 million in 2023, then increased by 12.19% to $393.9 million in 2024, then soared by 43.53% to $565.3 million in 2025.
  • Business Quant data shows Gross Profit for GMED at $565.3 million in Q4 2025, $516.5 million in Q3 2025, and $496.6 million in Q2 2025.